offline
Medtronic Reports Strong Surgical Product Sales on Way to Earnings Beat
Medtronic raises its full-year earnings forecast above analysts' estimates.
...
The company reported revenue of $2.12 billion, thanks in part to higher sales in its surgical products and restorative therapies divisions, topping analysts' expectations of $2.08 billion. Earnings of $1.29 per cents per share also came in ahead of analyst guidance by a nickel.
The company said that it expects full-year earnings to be in the range of $5.14 and $5.16 per share, up from its previous forecast between $5.10 and $5.15 per share. Analysts are expecting company to report earnings of $5.12 per share.
...
https://www.thestreet.com/investing/earn...yptr=yahoo
![[Bild: MDTc1dl1355.png]](https://finviz.com/publish/021919/MDTc1dl1355.png)
Medtronic raises its full-year earnings forecast above analysts' estimates.
...
The company reported revenue of $2.12 billion, thanks in part to higher sales in its surgical products and restorative therapies divisions, topping analysts' expectations of $2.08 billion. Earnings of $1.29 per cents per share also came in ahead of analyst guidance by a nickel.
The company said that it expects full-year earnings to be in the range of $5.14 and $5.16 per share, up from its previous forecast between $5.10 and $5.15 per share. Analysts are expecting company to report earnings of $5.12 per share.
...
https://www.thestreet.com/investing/earn...yptr=yahoo
__________________
